* Adapthealth Corp AHCO.OQ AHCO.O is expected to show a
rise
in quarterly revenue when it reports results
* The Plymouth Meeting Pennsylvania-based company is
expected to
report a 5.3% increase in revenue to $796.598 million from
$756.5 million a year ago, according to the mean estimate from
10 analysts, based on LSEG data. The company's guidance on
August 8 2023, for the period ended September 30, was for
revenue of $794.320 million.
* Refinitiv's mean analyst estimate for Adapthealth Corp is
for
earnings of 19 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Adapthealth
Corp
is $16.5, above its last closing price of $7.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.10 0.10 0.09 Missed -11.5
Mar. 31 2023 0.08 0.08 0.11 Beat 42.6
Dec. 31 2022 0.25 0.28 -0.02 Missed -107
Sep. 30 2022 0.31 0.31 0.11 Missed -64.7
Jun. 0.25 0.26 0.09 Missed -65
30 2022
Mar. 31 2022 0.19 0.18 0.08 Missed -55.6
Dec. 31 2021 0.32 0.34 0.17 Missed -50.8
Sep. 30 2021 0.27 0.28 0.20 Missed -28.6
This summary was machine generated November 3 at 17:04 GMT. All
figures in US dollars unless otherwise stated